{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:53:29Z","timestamp":1789620809933,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2687,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.bbmt.2007.08.002","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T17:09:44Z","timestamp":1196096984000},"page":"1448-1454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients"],"prefix":"10.1016","volume":"13","author":[{"given":"Enric","family":"Carreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rosi\u00f1ol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Terol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Alegre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"de Arriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Garc\u00eda-Lara\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimundo","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jes\u00fas","family":"Pe\u00f1arrubia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concha","family":"Poder\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paz","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Blad\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Lahuerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.08.002_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0609.2000.9r200.x","article-title":"Veno-occlusive disease of the liver after hemopoietic cell transplantation","volume":"64","author":"Carreras","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.08.002_bib3","first-page":"3599","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib4","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1182\/blood-2005-03-1301","article-title":"High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA","volume":"106","author":"Blad\u00e9","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2141.2000.01979.x","article-title":"Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma","volume":"109","author":"Lahuerta","year":"2000","journal-title":"Br\u00a0J Haematol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2141.1995.tb05307.x","article-title":"Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma","volume":"91","author":"Alegre","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib7","first-page":"52","article-title":"Autologous peripheral blood stem cell transplantation as first-line treatment of multiple myeloma: an Italian Multicenter Study","volume":"85","author":"Tribalto","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.08.002_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.08.002_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","article-title":"Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation","volume":"24","author":"Toh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1083-8791(99)70006-6","article-title":"Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome","volume":"5","author":"Lee","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib11","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2002-11-3567","article-title":"Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells","volume":"102","author":"Bornhauser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib12","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.bmt.1704353","article-title":"Pharmacokinetics of high-dose chemotherapy","volume":"33","author":"Nieto","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 4","key":"10.1016\/j.bbmt.2007.08.002_bib14","first-page":"18","article-title":"Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens","volume":"20","author":"Grochow","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib15","first-page":"31","article-title":"Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics","volume":"16","author":"Slattery","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib16","first-page":"225","article-title":"Association of busulfan area under the curve with veno-occlusive disease following BMT","volume":"17","author":"Dix","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib17","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood.V89.8.3055","article-title":"Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation","volume":"89","author":"Slattery","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00007691-199810000-00017","article-title":"Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation","volume":"20","author":"Slattery","year":"1998","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2007.08.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2478.x","article-title":"Absence of veno-occlussive disease in a cohort of multiple myeloma patients undergoing autologous stem cell transplantation with targeted busulfan dosage","volume":"77","author":"Clapes","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib20","first-page":"759","article-title":"Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted?","volume":"14","author":"Schuler","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2008-1040481","article-title":"Importance and regulation of hepatic glutathione","volume":"10","author":"DeLeve","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bbmt.2007.08.002_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Glutathione metabolism and its implications for health","volume":"134","author":"Wu","year":"2004","journal-title":"J Nutr"},{"key":"10.1016\/j.bbmt.2007.08.002_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000028359","article-title":"Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes","volume":"60","author":"DeLeve","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.bbmt.2007.08.002_bib24","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","article-title":"Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation","volume":"101","author":"McDonald","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.bmt.1704611","article-title":"Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation","volume":"34","author":"Ferrara","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib26","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.1995.13.7.1786","article-title":"High-dose intravenous melphalan: a review","volume":"13","author":"Samuels","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib27","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1200\/JCO.1996.14.11.2984","article-title":"Double-dose\u2013intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin","volume":"14","author":"Ayash","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib28","first-page":"1049","article-title":"Melphalan alone prior to allogeneic bone marrow transplantation from HLA- identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women","volume":"18","author":"Singhal","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib29","first-page":"227","article-title":"High-dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in France","volume":"5","author":"Viens","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2141.1996.d01-1932.x","article-title":"A pilot study of 220 mg\/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity","volume":"95","author":"Moreau","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib31","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1182\/blood.V79.11.2827.bloodjournal79112827","article-title":"Double-intensive therapy in high-risk multiple myeloma","volume":"79","author":"Harousseau","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2005-06-2573","article-title":"Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol","volume":"107","author":"Moreau","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib33","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up front with high-dose chemotherapy followed by autologous stem cell transplantation","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2007.08.002_bib34","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1182\/blood-2005-12-4898","article-title":"Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma","volume":"107","author":"Stewart","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.08.002_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1700913","article-title":"BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors","volume":"20","author":"Caballero","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/02656739209052883","article-title":"Enhancement of melphalan-induced gastrointestinal toxicity in mice treated with regional hyperthermia and BSO-mediated glutathione depletion","volume":"8","author":"Laskowitz","year":"1992","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.bbmt.2007.08.002_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cbi.2005.03.003","article-title":"Metabolism of melphalan by rat liver microsomal glutathione S-transferase","volume":"152","author":"Zhang","year":"2005","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bbmt.2007.08.002_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10428190210194","article-title":"Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma","volume":"43","author":"Lahuerta","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2007.08.002_bib39","first-page":"465","article-title":"High-dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non-Hodgkin's lymphoma","volume":"8","author":"Loiseau","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib40","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1991.9.10.1880","article-title":"Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy","volume":"9","author":"Phillips","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib41","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1208\/ps010314","article-title":"Inhibition of carboxyethylphosphoramide mustard formation from 4-hydroxycyclophosphamide by carmustine","volume":"1","author":"Ren","year":"1999","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.bbmt.2007.08.002_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2003.10.017","article-title":"Compartmental inhibition of hepatic glutathione reductase activities by 1,3-bis(2-chloroethyl)-N-nitrosourea (BCNU) in Sprague-Dawley and Fischer-344 rats","volume":"147","author":"Jopperi-Davis","year":"2004","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bbmt.2007.08.002_bib43","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/1097-0142(19881001)62:7<1275::AID-CNCR2820620705>3.0.CO;2-I","article-title":"Glutathione monoethyl ester can selectively protect liver from high-dose BCNU or cyclophosphamide","volume":"62","author":"Teicher","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2007.08.002_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.thj.6200369","article-title":"Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma","volume":"5","author":"Ria","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.bbmt.2007.08.002_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1444-0903.2004.00552.x","article-title":"Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approach","volume":"34","author":"Horvath","year":"2004","journal-title":"Intern Med J"},{"key":"10.1016\/j.bbmt.2007.08.002_bib46","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1200\/JCO.2005.03.0551","article-title":"High-dose therapy and autologous blood stem cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe","volume":"23","author":"Fermand","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.08.002_bib47","first-page":"323","article-title":"Busulphan and melphalan prior to autologous bone marrow transplantation","volume":"12","author":"Srivastava","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib48","first-page":"69","article-title":"Busulphan and melphalan prior to autologous transplantation for myeloid malignancies","volume":"16","author":"Cony-Makhoul","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib49","first-page":"596","article-title":"Ten-year follow-up of a single-center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early-phase chronic myeloyd leukemia","volume":"86","author":"Meloni","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.08.002_bib50","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1399-3046.2005.00359.x","article-title":"Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma","volume":"9","author":"Drabko","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0305-7372(03)00133-6","article-title":"Prevention of chemotherapy and radiation toxicity with glutamine","volume":"29","author":"Savarese","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bbmt.2007.08.002_bib52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/hep.510310224","article-title":"Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat","volume":"31","author":"Wang","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2007.08.002_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.08.002_bib54","first-page":"285","article-title":"Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan","volume":"90","author":"Kim","year":"2005","journal-title":"Haematologica"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107003795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107003795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:30:49Z","timestamp":1761057049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107003795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1083879107003795"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.08.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}